Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis
NCT 05037760 Brief Summary This is a Phase 2, multicenter, open-label study…
Read more arrow_forwardNCT 05037760 Brief Summary This is a Phase 2, multicenter, open-label study…
Read more arrow_forwardNCT 04581512 Brief Summary A research study looking at a new treatment…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.